Tuesday, October 28, 2025
Clinical Workshops
Workshop A, Panel 1: Starting an AID System
Moderators
Victoria Hsiao, MD, PhD
Endocrinology Clinic,
University of California at San Francisco,
San Francisco, CA, USA
University of California at San Francisco,
San Francisco, CA, USA
Robert Bém, MD, PhD
Institute for Clinical and Experimental Medicine, Prague, Czech Republic
8:00
Starting a Person on an AID System
Christie Beatson, RD, CDCES
Barbara Davis Center, University of Colorado Anschutz Medical Campus,
Aurora, CO, USA
Aurora, CO, USA
8:18
Comparison of AID Algorithms
Megan McGuigan, RN, CDCES
Diabetes Teaching Center,
University of California at San Francisco,
San Francisco, CA, USA
University of California at San Francisco,
San Francisco, CA, USA
8:36
Murphy's Law With AID Systems: Things That Can Go Wrong, Often Do, and Can Be Dangerous!
Steve Edelman, MD
University of California, San Diego,
San Diego, CA, USA
San Diego, CA, USA
8:54
Using an AID to Improve Glycemic Outcomes
Halis Kaan Akturk, MD
Barbara Davis Center for Diabetes, University of Colorado, Aurora, CO, USA
9:12
Q+A
9:20
BREAK
Workshop A, Panel 2: Getting the Most Value from a CGM
Moderators
Moshe Phillip, MD
Schneider Children's Medical Center, Petah Tikva, Israel
Guillermo Umpierrez, MD
Emory University, Atlanta, GA, USA
9:50
How to Interpret CGM Results
Richard Bergenstal, MD
International Diabetes Center,
Minneapolis, MN, USA
Minneapolis, MN, USA
10:08
Software for Managing CGM Data
Ralph Oiknine, MD
SweetSpot, St. Louis, MO, USA
10:26
Getting the Most Value from a CGM In the Hospital
Irl B. Hirsch, MD
University of Washington,
Seattle, WA, USA
Seattle, WA, USA
10:44
Precision Diabetes: CGM responses and diabetes subphenotypes
Michael Snyder, PhD
Department of Genetics, Stanford University, Palo Alto, CA, USA
11:02
CGM for Managing the Diet in Diabetes
David Kerr, MBChB, DM, FRCP, FRCPE
Sutter Health, Santa Barbara, CA, USA
11:20
Q+A
11:30
LUNCH
Workshop A, Panel 3: Artificial Intelligence for Clinicians
Moderators
David Scheinker, PhD
Department of Pediatrics Endocrinology, Stanford University, CA, USA
Michael McShane, PhD
Texas A&M University,
College Station, TX, USA
College Station, TX, USA
13:10
Introduction to AI for Medicine
Shahid N. Shah, MSc
Netspective Foundation,
Silver Spring, MD, USA
Silver Spring, MD, USA
13:30
Applying AI to Pediatric Diabetes Care
Risa Wolf, MD
Johns Hopkins University,
Baltimore, MD, USA
Baltimore, MD, USA
13:50
Embedding AI in a Mobile App
Leah Wilson, MD
Oregon Health & Science University, Portland, OR, USA
14:10
Clinical Applications of AI
Jing Wang, PhD, MPH, RN, FAAN
Florida State University College of Nursing, Tallahassee, FL, USA
14:25
AI for Diabetes Prevention
Nestoras Mathioudakis, MD, MHS
Johns Hopkins University,
Baltimore, MD, USA
Baltimore, MD, USA
14:40
Advanced Sensor Data and AI in Diabetes and Obesity Management: Welldoc's Digital Health Platform
Priya Jaisinghani, MD
NYU Grossman School of Medicine,
New York, NY, USA
New York, NY, USA
14:55
Q+A
15:05
BREAK
Workshop A, Panel 4: Debate: Which is More Useful for Treating Diabetes - CGM or GLP-1RAs?
Moderator
Robert Gabbay, MD, PhD
Joslin Diabetes Center, Boston, MA, USA
15:35
Favoring CGMs
Grazia Aleppo, MD
Northwestern University,
Chicago, IL, USA
Chicago, IL, USA
15:48
Favoring GLP-1RAs
Eugene Wright, MD
Department of Medicine,
Duke University Medical Center,
Durham, NC, USA
Duke University Medical Center,
Durham, NC, USA
16:01
Against GLP-1RAs
Julia Mader, MD
Medical University of Graz, Graz, Austria
16:14
Against CGMs
Sun Kim, MD, MS
Stanford University, Stanford, CA, USA
16:27
Conclusions
Grazia Aleppo, MD
Northwestern University,
Chicago, IL, USA
Chicago, IL, USA
Eugene Wright, MD
Department of Medicine,
Duke University Medical Center,
Durham, NC, USA
Duke University Medical Center,
Durham, NC, USA
16:29
Summary
Robert Gabbay, MD, PhD
Joslin Diabetes Center, Boston, MA, USA
16:35
Poster Session
Technical Workshops
Workshop B, Panel 1: Cybersecurity and Interoperability
Moderators
Patrick Phelan, BS
University of California at San Francisco, San Francisco, CA, USA
Ravi Subramaniam, MBA
IEEE Standards Association,
Piscataway, NJ, USA
Piscataway, NJ, USA
8:00
Cybersecurity of Diabetes Devices
Aiman Abdel-Malek, PhD
Thirdwayv Inc. and Apex Medical AI Inc.,
La Jolla, CA, USA
La Jolla, CA, USA
8:18
The IEEE 2621 Cybersecurity Standard
Naomi Schwartz, MS, CQA
Medcrypt, Solana Beach, CA, USA
8:36
Interoperability Solutions in the U.S.
Juan Espinoza, MD
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA
8:54
Interoperability Solutions in Europe
Pietro Randine, PhD
UiT The Arctic University of Norway, Tromsø, Norway
9:12
Q+A
9:20
BREAK
Workshop B, Panel 2: Multimodal Sensors
Moderators
Mark Arnold, PhD
University of Iowa, Iowa City, IA, USA
Koji Sode, PhD
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
9:50
Multisensor Arrays for Diabetes
Joseph Wang, PhD
University of California, San Diego,
San Diego, CA, USA
San Diego, CA, USA
10:08
Insertable Multi-Metabolite Sensors for Diabetes
Michael McShane, PhD
Texas A&M University,
College Station, TX, USA
College Station, TX, USA
10:26
Co-immobilization for a dual marker insulin-glucose electrochemical biosensor
Jeff La Belle, PhD
Grand Canyon University,
Phoenix, AZ, USA
Phoenix, AZ, USA
10:44
Combining ketone and glucose monitoring
Shridhara Alva, PhD
Abbott Diabetes Care, Alameda, CA, USA
11:02
Multi-Analyte Semiconductor Biosensors
Jared Tangney, PhD
Biolinq, San Diego, CA, USA
11:20
Q+A
11:30
LUNCH
Workshop B, Panel 3: CGM Data Presentation
Moderators
Peter Calhoun, PhD
Jaeb Center for Health Research,
Tampa, FL, USA
Tampa, FL, USA
Guido Freckmann, MD
Institute for Diabetes Technology at Ulm University, Ulm, Germany
13:10
A Complete View of Data Using the Diabetes Research Hub
Juan Espinoza, MD
Ann & Robert H. Lurie Children's Hospital of Chicago, IL, USA
13:30
Actionable Data Presentation
Mark Clements, MD, PhD, CPI, FAAP
Glooko, Inc. Palo Alto, CA, USA
13:50
New Dimensions for Analyzing CGM Data
Boris Kovatchev, PhD
University of Virginia,
Charlottesville, VA, USA
Charlottesville, VA, USA
14:10
Improving Outcomes by Empowering Care Providers with CGM Data
David Scheinker, PhD
Department of Pediatrics Endocrinology, Stanford University, Palo Alto, CA, USA
14:30
Q+A
14:40
BREAK
Workshop B, Panel 4: New Technology to Measure Glucose
Moderators
Jeff La Belle, PhD
Grand Canyon University,
Phoenix, AZ, USA
Phoenix, AZ, USA
Frank Doyle Jr., PhD
Brown University, Providence, RI, USA
15:10
Benchmarking Noninvasive Glucose Measurements
Mark Arnold, PhD
University of Iowa, Iowa City, IA, USA
15:25
Osmotic Glucose Monitoring
Andreas Pfützner, MD, PhD
Pfützner Science & Health Institute,
Mainz, Germany
Mainz, Germany
15:40
Continuously Monitored Blood Glucose
Paul Goode, PhD
Glucotrack, Rutherford, NJ, USA
15:55
Glycated Albumin
Koshin Sekimizu, PhD
Provigate Inc., Tokyo, Japan
16:10
The Future of Continuous Monitoring in Type 1 Diabetes: Moving Beyond CGM
Amin Ghavami Nejad, PhD
Breakthrough T1D, New York, NY, USA
16:25
Q+A
16:35
Poster Session
Wednesday, October 29, 2025
8:00
Welcome
David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center (Sutter Health), San Mateo, CA, USA
8:10
Keynote Speaker
Rita Kalyani, MD, MHS
President, Medicine & Science, American Diabetes Association and Johns Hopkins University, Baltimore, MD, USA
Session 1: Emerging Trends of Diabetes Technology
Moderators
David Kerr, MBChB, DM, FRCP, FRCPE
Sutter Health, Santa Barbara, CA, USA
Richard Bergenstal, MD
International Diabetes Center, Minneapolis, MN, USA
8:30
Panel Discussion
Danielle Antalffy, BA
Equity Research -- U.S. Medical Supplies & Devices, UBS, New York, NY, USA
Erich Huang, MD, PhD
Verily, Dallas, TX, USA
Moshe Phillip, MD
Schneider Children's Medical Center, Petah Tikva, Israel
David Walton, MBA
T1D Exchange, Boston, MA, USA
9:35
BREAK
Session 2: AI for Better Diabetes Products
Moderators
Fredrik DeBong, BS
Syntactiq, Vienna, Austria
Nestoras Mathioudakis, MD, MHS
Johns Hopkins University, Baltimore, MD, USA
10:05
Applying AI to Product Building
Shahid N. Shah, MSc
Netspective Foundation, Silver Spring, MD, USA
10:17
The Future of AI for Healthcare
Renee Yao, MBA
NVIDIA, Santa Clara, CA, US
10:29
Dexcom's AI Initiatives
Karan Bhatia, PhD
Dexcom, Inc., San Diego, CA, USA
10:41
Advancing Insulin Dosing with AI
Michael Stone, BA
Medtronic Diabetes, Northridge, CA, USA
10:53
Q+A
Session 3: Hospital Technology
Moderators
Jane Seley, DNP MPH MSN GNP BC-ADM CDCES CDTC FADCES
Weill Cornell Medicine, New York City, NY, USA
Halis Kaan Akturk, MD
Barbara Davis Center for Diabetes, University of Colorado, Aurora, CO, USA
11:00
CGM in the Hospital
Guillermo Umpierrez, MD
Emory University, Atlanta, GA, USA
11:15
An Automated Algorithm for Hospitalized Patients
Robert Rushakoff, MD, MS
University of California, San Francisco, San Francisco, CA, USA
11:30
LUNCH
Session 4: Metrics for CGM Measurements
Moderators
Michael Kohn, MD, MPP
University of California at San Francisco, San Francisco, CA, USA
Sonali Thosani, MD, CMQ, FEAA, FACE
Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, TX, USA
13:10
The IFCC Analytical Accuracy Consensus
Guido Freckmann, MD
Institute for Diabetes Technology at Ulm University, Ulm, Germany
13:25
Using CGM metrics to Personalize Diabetes Care
Richard Bergenstal, MD
International Diabetes Center, Minneapolis, MN, USA
13:40
Tight Time in Range in Children
David Maahs, MD, PhD
Stanford University, Stanford, CA, USA
13:55
The Glycemia Risk Index
Viral Shah, MD
Indiana University, Indianapolis, IN, USA
14:10
Time in Tight Range in Adults
Peter Calhoun, PhD
Jaeb Center for Health Research, Tampa, FL, USA
14:25
Q+A
14:40
BREAK
Session 5: Artificial Pancreas
Moderators
Jeffrey Joseph, DO
Thomas Jefferson University Hospital, Philadelphia, PA, USA
Eda Cengiz, MD, MHS
Pediatric Diabetes Program, University of California at San Francisco, San Francisco, CA, USA
15:10
Artificial Pancreas Award
David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center (Sutter Health), San Mateo, CA, USA
15:15
Neural Network for AID Control
Boris Kovatchev, PhD
University of Virginia, Charlottesville, VA, USA
15:30
Using Adjuvant Medications with AID Systems
Ahmad Haidar, PhD
McGill University, Montréal, QC, Canada
15:45
Use of an AID System During Ramadan
Mohammed Al-Sofiani, MBBS, MSc
King Saud University, College of Medicine, Riyadh, Saudi Arabia
Johns Hopkins University, Baltimore, MD, USA
Johns Hopkins University, Baltimore, MD, USA
16:00
AID Systems without Meal Announcements
Rayhan Lal, MD
Stanford Diabetes Research Center, Stanford, CA, USA
16:15
Me and My AID
Patient 1
Patient 2
16:25
Q+A
16:35
Poster Session
Thursday, October 30, 2025
Session 6: Novel Drugs and Drug Delivery Systems
Moderators
Andreas Pfützner, MD, PhD
Pfützner Science & Health Institute, Mainz, Germany
Umesh Masharani, MD
University of California San Francisco, San Francisco, CA, USA
8:00
Student Award Presentation
Student Award Winner
8:15
Ultra-long Acting Insulin
Tim Heise, MD
Profil, Neuss, Germany
8:30
New Uses for GLP-1RAs
Sun Kim, MD
Stanford University, Stanford, CA, USA
8:45
Avoiding Muscle Atrophy from GLP-1RAs
G. Alexander Fleming, MD
Kinexum, Harpers Ferry, WV, USA
9:00
Q+A
9:10
BREAK
Session 7: New Uses of CGM Systems
Moderators
Michael Snyder, PhD
Department of Genetics, Stanford University, Palo Alto, CA, USA
Tracey McLaughlin, MD
Department of Medicine, Stanford University, Palo Alto, CA, USA
9:40
CGM metrics in Healthy People
Viral Shah, MD
Indiana University, Indianapolis, IN, USA
9:55
Identifying Prediabetes and Early T2D Based on Metabolic Features
Ahmed Metwally, PhD
Google Research, Mountain View, CA, USA
10:10
CGM to Diagnose Stage 2 T1D for Immune Therapy
Jenise Wong, MD, PhD
University of California San Francisco, San Francisco, CA, USA
Julia Mader, MD
Medical University of Graz, Graz, Austria
10:25
Q+A
10:40
BREAK
Session 8: CGM Technology
Moderators
Lutz Heinemann, PhD
Science Consulting in Diabetes, Düsseldorf, Germany
Kayo Waki, MD, MPH, PhD
University of Tokyo Graduate School of Medicine, Tokyo, Japan
10:45
Advances in CGM Technology
Jessica Castle, MD
Dexcom, Inc., San Diego, CA, USA
10:55
Advances in CGM Technology
Robert Mucic, PhD
Medtronic Diabetes, Northridge, CA, USA
11:05
Advances in CGM Technology
Ana Yufera Sánchez, MD
Roche Diagnostics International, Rotkreuz, Switzerland
11:15
Unlocking the Benefits of CGM in Type 2 Diabetes: FreeDM2 Trial, Methods, and Primary Outcome
Emma Wilmot, MD
University of Nottingham, Derby, UK
11:25
Q+A
Special Session
11:30
Update in Regulation of Diabetes Technology (Remote)
Courtney H. Lias, PhD
Director, OHT7: Office of In Vitro Diagnostic Devices,
U.S. Food and Drug Administration, Silver Spring, MD, USA
U.S. Food and Drug Administration, Silver Spring, MD, USA
12:00
LUNCH
Session 9: Diabetes Center Berne Open Innovation Challenge
Moderator
Hanne Ballhausen, BSc, MSc
Diabetes Center Berne, Bern, Switzerland
13:10
Introduction
Simon Schwaighofer, MD
Diabetes Center Berne, Bern, Switzerland
13:20
DCB Open Innovation Challenge Finalist Presentation
Company 1 Finalist
13:30
DCB Open Innovation Challenge Finalist Presentation
Company 2 Finalist
13:40
DCB Open Innovation Challenge Finalist Presentation
Company 3 Finalist
13:50
DCB Open Innovation Challenge Finalist Presentation
Company 4 Finalist
14:00
DCB Open Innovation Challenge Finalist Presentation
Company 5 Finalist
14:10
Q+A
14:20
BREAK
Session 10: Hot Topics
11:02
Moderators
David Kerr, MBChB, DM, FRCP, FRCPE
Sutter Health, Santa Barbara, CA, USA
David Black, PhD, MPH
Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA
14:50
How Diabetes Waste Affects the Environment
Lutz Heinemann, PhD
Science Consulting in Diabetes, Düsseldorf, Germany
15:05
How the Environment Affects Diabetes
Sultan Meo, MBBS, Ph.D, MMed Ed, FRCP
College of Medicine, King Saud University, Riyadh, Saudi Arabia
15:20
Why C-peptide is Necessary and More than Sufficient for Approving Disease Modifying Treatments for T1D
G. Alexander Fleming, MD
Kinexum, Harpers Ferry, WV, USA
15:35
The Human Side of Diabetes Technology: Evolving Use, New Expectations, and Differences around the World
Kyle J. Rose, BS
International Diabetes Federation, Los Angeles, CA, USA
15:50
Sensor Data, Patient-reported Outcome Measures and other Secondary Outcomes from the FreeDM2 Study
Lala Leelarathna, PhD
Imperial College London, London, UK
16:05
Q+A
16:20
BREAK
Session 11: Live Demo
Moderators
Jane Seley, DNP MPH MSN GNP BC-ADM CDCES CDTC FADCES
Weill Cornell Medicine, New York City, NY, USA
Dorian Liepmann, PhD
University of California at Berkeley, Berkeley, CA, USA
16:25
AI-Powered Personalized Nutritionist for Diabetes Care
Yao Qin, PhD
University of California, Santa Barbara, Santa Barbara, CA, USA
16:35
Q+A
16:40
ADJOURN